| Israel | Turkey | Austria | |
| Pituitary tumor surgery | from $28,000 | from $13,500 | from $30,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Pituitary tumor surgery upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pituitary tumor surgery and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pituitary tumor surgery journey.
Day 1
Day 2
Day 3
Day 4
Day 5-7
Week 2
Week 3-6
Week 7
Please note that each patient"s recovery timeline may vary based on individual health status and the complexity of the surgery.
Dr. Zvi Cohen is the Director of the Neurosurgery Department at Sheba Medical Center. He was recently recognized in Forbes Israel’s Best Doctors list for 2025. Dr. Cohen specializes in treating complex brain, pituitary, and spinal cord tumors. He founded the brain tumor tissue bank at Sheba to support oncological research. Dr. Cohen is board-certified in neurosurgery and leads clinical trials for malignant brain tumors.
Dr. Anton Wohl is the Director of the Brain Tumors Unit at Sheba Medical Center. He specializes in neuro-oncology and complex brain tumor surgery. He completed fellowships at the Mayo Clinic in the USA. Dr. Wohl works at a hospital ranked 7th globally by Newsweek in 2026. He focuses on removing tumors while preserving neurological function.
Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.
Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.